Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Taspoglutide versus placebo in drug-naïve type 2 diabetes mellitus patients inadequately controlled with diet and exercise
2008-001765-28Phase 3Completed
- Sponsor
- Roche
- Start
- Jul 2008
- Modality
- Peptides
- Countries
- 1
01
Overview
Phase 3, randomised, double-blind trial in type 2 diabetes mellitus (T2DM) comparing Taspoglutide with Placebo (2 arms). Primary endpoint: Change in HbA1c from baseline at 24 weeks. Started Jul 2008; status: completed.
02
Drugs
taspoglutide
03
Conditions
type 2 diabetes mellitus (T2DM)
Beyond the preview
Go deeper on 2008-001765-28.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2008-001765-28.